Coming to you from Tokyo on the Making Medicine Podcast

To cap off a successful trip to Japan, Incubate executive director John Stanford sat down with a panel of biotech investors, founders, and industry leaders for an episode of the Making Medicine podcast. John was joined by Shaan Gandhi of Pfizer, Patrick Jordan of NovaQuest Capital Management, Heather Berger of Forge Life Science Partners, and Johannes Fruehauf of BioLabs Global Inc to discuss Japan's emerging biotech hub.

Japan's life sciences sector is growing quickly, driven by regulatory updates, new incentives, and a surge of entrepreneurial energy. Long seen as a cautious market, the country is now creating the conditions needed to advance regenerative medicine, gene therapy, and the broader bioeconomy.

The panel outlines how faster review pathways, expanding innovation hubs, and a more active investment environment are reshaping Japan's biotech landscape. They describe the episode as a crash course for U.S. biotechs considering expansion into Japan, and note they were impressed by the unified support from the Japanese government and the energy across the ecosystem.

Momentum is clearly building, and Japan is emerging as biotech's rising star -- leveraging its scientific depth and policy reforms to challenge the sector's mainstays.

Check out the Making Medicine podcast on YouTube, Spotify, or Apple Podcasts!